SLC15A1 and cancer: None of the currently available anticancer drugs are substrates of PEPT1, but several prodrugs and anticancer-drug-loaded nanoparticles targeting PEPT1 for enhanced oral bioavailability or cancer cell uptake have been published [312,313,314,315,316].